Valeant Pharmaceuticals expanded Bausch + Lomb contact lens manufacturing in Rochester, N.Y.
LAVAL, Que.—A Quebec-based pharmaceutical company has cut the ribbon on an expanded contact lens manufacturing facility in Rochester, N.Y., where it has hired 120 new employees.
Valeant Pharmaceuticals International, Inc. celebrated the official opening this week of its expanded Optics Center in Rochester, N.Y., where it will produce its silicone hydrogel contact lens under the Bausch + Lomb brand.
“Our Rochester facility is a very important piece of our strategy to rebuild Bausch + Lomb as one of the leading contact lens producers,” Valeant chair and CEO J. Michael Pearson said in a release.
“Our Rochester Optics Center is a first-in-class manufacturing site for contact lens manufacturing and distribution, and with the new contact lens manufacturing lines, we will add much needed production capacity to supply both current and future demand.”
The facility in Western New York will also feature a solar installation that will feature 3,667 photovoltaic (PV) panels when complete.
The solar array, currently under construction, will cut the facility’s carbon emissions by about 800 tonnes a year, according to the company.
A completion date was not provided.